Precise execution

MC Services is...

Client News



… an international Corporate Communications and Investor Relations firm providing high-level consultancy with targeted services and support for transaction-oriented assignments throughout Europe and the United States.


read more


MC Services sponsors Best Technology Award at the 2016 European Mediscience Awards


MC Services is proud to contribute to this year’s European Mediscience Awards as a sponsor of the Best Technology Award, for innovative technology that is well funded and capable of significant commercial success.

A shortlist of finalists will be published on 6 May 2016!

read more


MC Services is attending "Deutsche Biotechnologietage 2016" (DBT)


As a steadily growing event the DBT (German Biotech Days) have become one of the leading national industry events for the biotech industry. MC Services will attend this year’s edition of the conference which will take place in Leipzig from April 26 to 27 and will bring together over 800 industry experts representing businesses, scientific organizations and governmental institutions. Discussing the conditions for innovation in biotechnology and the wide range of biotech applications, the event will feature a series of key notes, panel discussions and breakfast sessions.


Contact us to arrange a meeting at the DBT 2016.


Please also follow us on Twitter (@MCServicesAG)

Proposed acquisition of Haemostatix Limited


MorphoSys to Present at Three Upcoming Conferences


Verona to present clinical data on RPL554 at the ATS International Conference 


Apogenix to Present at Two Upcoming International Conferences


VAXIMM initiates Phase 2a study in advanced colorectal cancer with oral T-cell vaccine VXM01


Aufsichtsrat der NanoRepro AG verlängert Vorstandsvertrag mit Lisa Jüngst


Adocia strengthens its BioChaperone Combo patent portfolio 


MorphoSys AG Reports Results for the First Three Months of 2016


China FDA names Epigenomics’ blood-based Septin9 colorectal cancer test a most innovative medical product for 2015


RedHill Biopharma Reports 2016 First Quarter Financial Results